I promised this in a previous post. From Who needs myopia control? in the September 2021 issue of International Journal of Ophthalmology Basically, if your patient is at least a certain amount nearsighted at a certain age, they have a higher risk of developing high myopia.

Read More

A standard warning in investing is that prior performance does not predict future results. Can the same thing be said about myopia progression? The article The Limited Value of Prior Change in Predicting Future Progression of Juvenile-Onset Myopia: Optometry and Vision Science published in the May 2022 edition of Optometry and Vision Science purports that […]

Read More

Readers of this site will know I’m a sucker for a new myopia control article. Xu Cheng, MD, PhD, et al published Randomized trial of soft contact lenses with novel ring focus for controlling myopia progression in Ophthalmology Science in October 2022. One of the biggest issues with myopia control is balancing the quality of […]

Read More

In my post Red light therapy for myopia control, I came across the concept of a potential mechanism for myopia control. Scleral hypoxia. Though my knowledge of molecular biology is significantly lacking. I found the results and discussion of these pathways utterly fascinating. I read through two papers: Scleral Mechanisms Underlying Ocular Growth and Myopia […]

Read More

Red light therapy seems to be the new thing in regards to fixing everything from pre-mature aging of the skin, meibomian gland disease, and, it turns out, amblyopia. We intend to use a device that emits red light at 650 nm in wavelength based on the fact that it has already been approved and widely […]

Read More

I am linking to this mainly because it is not a journal article. This is a news website posting something for non-eye doctors. Thankfully, they got two people who are at the forefront of myopia research, Debbie Jones and Kate Gifford, to write the article. Simply spending more time outside can delay the onset of myopia. Direct […]

Read More